209 related articles for article (PubMed ID: 24511990)
1. Smad7 inhibits AngII-mediated hypertensive nephropathy in a mouse model of hypertension.
Liu GX; Li YQ; Huang XR; Wei LH; Zhang Y; Feng M; Meng XM; Chen HY; Shi YJ; Lan HY
Clin Sci (Lond); 2014 Aug; 127(3):195-208. PubMed ID: 24511990
[TBL] [Abstract][Full Text] [Related]
2. Deletion of Angiotensin-Converting Enzyme-2 Promotes Hypertensive Nephropathy by Targeting Smad7 for Ubiquitin Degradation.
Liu Z; Huang XR; Chen HY; Fung E; Liu J; Lan HY
Hypertension; 2017 Oct; 70(4):822-830. PubMed ID: 28808068
[TBL] [Abstract][Full Text] [Related]
3. MiR-101a ameliorates AngII-mediated hypertensive nephropathy by blockade of TGFβ/Smad3 and NF-κB signalling in a mouse model of hypertension.
Ding H; Zhou Y; Huang H
Clin Exp Pharmacol Physiol; 2019 Mar; 46(3):246-254. PubMed ID: 30304543
[TBL] [Abstract][Full Text] [Related]
4. Smad7 inhibits angiotensin II-induced hypertensive cardiac remodelling.
Wei LH; Huang XR; Zhang Y; Li YQ; Chen HY; Yan BP; Yu CM; Lan HY
Cardiovasc Res; 2013 Sep; 99(4):665-73. PubMed ID: 23761400
[TBL] [Abstract][Full Text] [Related]
5. Smad3 mediates ANG II-induced hypertensive kidney disease in mice.
Liu Z; Huang XR; Lan HY
Am J Physiol Renal Physiol; 2012 Apr; 302(8):F986-97. PubMed ID: 22237801
[TBL] [Abstract][Full Text] [Related]
6. Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF.κB-dependent mechanisms in mice.
Liu GX; Li YQ; Huang XR; Wei L; Chen HY; Shi YJ; Heuchel RL; Lan HY
PLoS One; 2013; 8(1):e53573. PubMed ID: 23301086
[TBL] [Abstract][Full Text] [Related]
7. Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice.
Ka SM; Yeh YC; Huang XR; Chao TK; Hung YJ; Yu CP; Lin TJ; Wu CC; Lan HY; Chen A
Diabetologia; 2012 Feb; 55(2):509-19. PubMed ID: 22086159
[TBL] [Abstract][Full Text] [Related]
8. Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice.
Ka SM; Huang XR; Lan HY; Tsai PY; Yang SM; Shui HA; Chen A
J Am Soc Nephrol; 2007 Jun; 18(6):1777-88. PubMed ID: 17475816
[TBL] [Abstract][Full Text] [Related]
9. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7.
Wang W; Huang XR; Li AG; Liu F; Li JH; Truong LD; Wang XJ; Lan HY
J Am Soc Nephrol; 2005 May; 16(5):1371-83. PubMed ID: 15788474
[TBL] [Abstract][Full Text] [Related]
10. Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy.
Liu Z; Huang XR; Chen HY; Penninger JM; Lan HY
Lab Invest; 2012 May; 92(5):650-61. PubMed ID: 22330342
[TBL] [Abstract][Full Text] [Related]
11. Blockade of NFkappaB activation and renal inflammation by ultrasound-mediated gene transfer of Smad7 in rat remnant kidney.
Ng YY; Hou CC; Wang W; Huang XR; Lan HY
Kidney Int Suppl; 2005 Apr; (94):S83-91. PubMed ID: 15752249
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of Smad7 enhances cardiac remodeling induced by angiotensin II infusion in a mouse model of hypertension.
Wei LH; Huang XR; Zhang Y; Li YQ; Chen HY; Heuchel R; Yan BP; Yu CM; Lan HY
PLoS One; 2013; 8(7):e70195. PubMed ID: 23894614
[TBL] [Abstract][Full Text] [Related]
13. Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chen HY; Zhong X; Chung AC; Lan HY
J Pathol; 2012 Jun; 227(2):175-88. PubMed ID: 22190171
[TBL] [Abstract][Full Text] [Related]
14. Integrin-linked kinase plays a key role in the regulation of angiotensin II-induced renal inflammation.
Alique M; Civantos E; Sanchez-Lopez E; Lavoz C; Rayego-Mateos S; Rodrigues-Díez R; García-Redondo AB; Egido J; Ortiz A; Rodríguez-Puyol D; Rodríguez-Puyol M; Ruiz-Ortega M
Clin Sci (Lond); 2014 Jul; 127(1):19-31. PubMed ID: 24383472
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound-microbubble-mediated gene transfer of inducible Smad7 blocks transforming growth factor-beta signaling and fibrosis in rat remnant kidney.
Hou CC; Wang W; Huang XR; Fu P; Chen TH; Sheikh-Hamad D; Lan HY
Am J Pathol; 2005 Mar; 166(3):761-71. PubMed ID: 15743788
[TBL] [Abstract][Full Text] [Related]
16. Smad7 protects against chronic aristolochic acid nephropathy in mice.
Dai XY; Zhou L; Huang XR; Fu P; Lan HY
Oncotarget; 2015 May; 6(14):11930-44. PubMed ID: 25883225
[TBL] [Abstract][Full Text] [Related]
17. Smad7 suppresses renal fibrosis via altering expression of TGF-β/Smad3-regulated microRNAs.
Chung AC; Dong Y; Yang W; Zhong X; Li R; Lan HY
Mol Ther; 2013 Feb; 21(2):388-98. PubMed ID: 23207693
[TBL] [Abstract][Full Text] [Related]
18. The protective role of Smad7 in diabetic kidney disease: mechanism and therapeutic potential.
Chen HY; Huang XR; Wang W; Li JH; Heuchel RL; Chung AC; Lan HY
Diabetes; 2011 Feb; 60(2):590-601. PubMed ID: 20980457
[TBL] [Abstract][Full Text] [Related]
19. Benazepril, an angiotensin-converting enzyme inhibitor, alleviates renal injury in spontaneously hypertensive rats by inhibiting advanced glycation end-product-mediated pathways.
Liu XP; Pang YJ; Zhu WW; Zhao TT; Zheng M; Wang YB; Sun ZJ; Sun SJ
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):287-96. PubMed ID: 19018797
[TBL] [Abstract][Full Text] [Related]
20. Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chung AC; Qin W; Chen HY; Lan HY
Kidney Int; 2012 Feb; 81(3):266-79. PubMed ID: 22048127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
